Dr. David Jing Piao Lin, MD

Dr. Lin practices at Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Lin's NPI, 1144668781, was assigned on June 5, 2013. Dr. Lin graduated from Harvard Medical School in 2013. Dr. Lin holds Massachusetts license 266088.

Dr. Lin's primary practice is Massachusetts General Hospital, at 55 Fruit Street, Boston, MA 02114 in Suffolk County. The practice phone is (617) 726-2000.

Dr. Lin's primary practice is Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Lin is also affiliated with Brigham and Women's Hospital. The medical group on file is Massachusetts General Physicians Organization (MGPO). Dmand AI also links Dr. Lin to 3 more hospitals, 7 medical groups, 2 group practices and clinics and 1 community health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 8 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Lin is licensed in Massachusetts.

CMS data shows 242 Medicare services from Dr. Lin across 2 procedure codes in 2024, for 122 Medicare patients. Medicare paid $41,779 for them.

CMS counts 122 Medicare patients who saw Dr. Lin in 2024. The largest group is 65 to 74, with 49 patients. 75% of them have high blood pressure, and 75% have stroke or tia. 33% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 66, with 51% women.

In 2024, Dr. Lin wrote 56 Medicare Part D claims for 14 patients. 98% of them were for generic drugs. CMS names the drug for 25 of them, across 2 drugs with 11 or more claims each, at $120 in total drug cost. In 2022, CMS named 11 claims across 1 drug.

Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lin as offering telehealth.

Dmand AI links 50 papers to Dr. Lin, published from 2012 to 2025. 2023 was the busiest year, with 10. The most frequent topics are Stroke, Stroke Rehabilitation and Recovery of Function. Dr. Lin has published most often in J Bone Miner Res. Dr. Lin's most frequent co-authors are Magdy H. Selim, MD, Alexander Andreev, MD and Steven C. Cramer, MD.

CMS Open Payments shows 19 general payments to Dr. Lin from 7 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 58% of the total. Bristol-Myers Squibb Company paid the most, $3,200.

Dr. Lin graduated from Harvard Medical School in 2013.